Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meir Wetzler

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Cancer Genetics and Cytogenetics|April 27, 2010
Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemiaNorma J Nowak, Sheila N J Sait, Amer Zeidan, et al.
American Journal of Hematology|February 5, 2015
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemiaAshkan Emadi, Rawan Faramand, Brandon Carter-Cooper, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2008
Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodiesAllison S Drake, Michael T Brady, Xin Hui Wang, et al.
Leukemia & Lymphoma|October 6, 2015
Incidence and management of myelosuppression in patients with chronic- and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinateLuke Akard, Hagop M Kantarjian, Franck E Nicolini, et al.
International Journal of Molecular Epidemiology and Genetics|February 12, 2011
Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid LeukemiaShalaka S Hampras, Lara Sucheston, Joli Weiss, et al.
Cancer|March 27, 2009
Treating octogenarian and nonagenarian acute myeloid leukemia patients--predictive prognostic modelsAntoine J Harb, Wei Tan, Gregory E Wilding, et al.
Leukemia Research|August 24, 2010
Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 casesSyed J Noor, Wei Tan, Gregory E Wilding, et al.
Leukemia & Lymphoma|February 20, 2016
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665Rebecca DeBoer, Gregory Koval, Flora Mulkey, et al.
International Journal of Molecular Epidemiology and Genetics|September 28, 2011
XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemiaNataliya Kuptsova-Clarkson, Christine B Ambrosone, Joli Weiss, et al.
British Journal of Haematology|July 25, 2015
Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxideDavid Sanford, Francesco Lo-Coco, Miguel A Sanz, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Cancer Genetics and Cytogenetics|April 27, 2010
Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemiaNorma J Nowak, Sheila N J Sait, Amer Zeidan, et al.
American Journal of Hematology|February 5, 2015
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemiaAshkan Emadi, Rawan Faramand, Brandon Carter-Cooper, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2008
Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodiesAllison S Drake, Michael T Brady, Xin Hui Wang, et al.
Leukemia & Lymphoma|October 6, 2015
Incidence and management of myelosuppression in patients with chronic- and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinateLuke Akard, Hagop M Kantarjian, Franck E Nicolini, et al.
International Journal of Molecular Epidemiology and Genetics|February 12, 2011
Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid LeukemiaShalaka S Hampras, Lara Sucheston, Joli Weiss, et al.
Cancer|March 27, 2009
Treating octogenarian and nonagenarian acute myeloid leukemia patients--predictive prognostic modelsAntoine J Harb, Wei Tan, Gregory E Wilding, et al.
Leukemia Research|August 24, 2010
Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 casesSyed J Noor, Wei Tan, Gregory E Wilding, et al.
Leukemia & Lymphoma|February 20, 2016
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665Rebecca DeBoer, Gregory Koval, Flora Mulkey, et al.
International Journal of Molecular Epidemiology and Genetics|September 28, 2011
XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemiaNataliya Kuptsova-Clarkson, Christine B Ambrosone, Joli Weiss, et al.
British Journal of Haematology|July 25, 2015
Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxideDavid Sanford, Francesco Lo-Coco, Miguel A Sanz, et al.
Pageof 12